women's health

The company also announced that it has received New York State Department of Health conditional approval for three women's health molecular diagnostic tests.

Revenues from the company's clinical labs segment grew 8 percent this quarter, and revenues from the life sciences business grew 6 percent.

The two companies said they will integrate their technologies to create a sample management and interpretation and reporting system.

The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.

LabCorp plans to acquire all of Sequenom's outstanding stock for $2.40 per share.

Cepheid said this week that it has launched Xpert HPV, a one-hour molecular test for cervical cancer-related human papillomaviruses, in Europe after receiving CE IVD marking.

Hologic last week scored a major win for its molecular diagnostics business as it announced it was entering into a strategic alliance with Quest Diagnostics to more broadly offer testing based on Hologic's Aptima family of products — a portfolio that Hologic garnered last year as

Hologic said this week that fiscal first-quarter clinical diagnostics revenues from Gen-Probe, acquired last summer, were up 9 percent over the comparable period last year, but that blood screening revenues contributed by Gen-Probe declined slightly year over year.

Hologic's planned $3.7 billion acquisition of Gen-Probe, announced earlier this week, is expected to create the largest diagnostics company focused on women's health, according to Hologic officials.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.